Unicycive Therapeutics

Unicycive Therapeutics

UNCY· Manufacturing· Fiscal year ends in December

CEO pay in FY2025Stock -27.3% in FY2025

Shalabh Gupta, M.D. is the CEO of Unicycive Therapeutics and was paid $2.4M in FY2025 (Dec), down 2%.

Pay$100 in the stock at the end of FY21 → $17
CEO pay is from each Unicycive Therapeutics proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Executives3

See all
  1. 1Shalabh Gupta, M.D.FY2025
  2. 2Pramod Gupta, Ph.D.FY2025
  3. 3Doug JermasekFY2025

Named executives and their total pay, from the Summary Compensation Table of the latest proxy.

Pay

See all

Unicycive Therapeutics paid its 3 named executives $3.9M in total in FY2025 (Dec). CEO Shalabh Gupta, M.D. was paid $2.4M of that.

Name
Shalabh Gupta, M.D.Chief Executive Officer
Pramod Gupta, Ph.D.Executive VP Pharmaceutical and Business Operations
Doug JermasekExecutive VP, Corporate Strategy

of each named executive, from the Summary Compensation Table of each proxy.

Peers

No disclosed peer group

No proxy on file names a pay peer group for Unicycive Therapeutics. The peer group comes from the proxy statement, so it shows here when a proxy read has it.

Activity

Filings6

See all
Proxy statementDEF 14AApr 30, 2026FY2025
Annual report10-KMar 30, 2026FY2025
Proxy statementDEF 14AApr 30, 2025FY2024
Annual report10-KMar 31, 2025FY2024
Proxy statementDEF 14AApr 26, 2024FY2023
Annual report10-KMar 28, 2024FY2023
For the press:Download CSVDownload PNGHow to use our data